Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02925104 |
| Title | A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors. |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | child | senior | adult |
| Covered Countries | USA | SWE | NLD | GBR | ESP | DNK | DEU | AUT |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Indiana University Simon Cancer Center SC | Indianapolis | Indiana | 46202 | United States | Details | |
| Novartis Investigative Site | Salzburg | 5020 | Austria | Details | ||
| Novartis Investigative Site | Herlev | 2730 | Denmark | Details | ||
| Novartis Investigative Site | Dresden | 01307 | Germany | Details | ||
| Novartis Investigative Site | Mainz | 55131 | Germany | Details | ||
| Novartis Investigative Site | Nijmegen | 6500 HB | Netherlands | Details | ||
| Novartis Investigative Site | Malaga | Andalucia | 29010 | Spain | Details | |
| Novartis Investigative Site | Santiago de Compostela | Galicia | 15706 | Spain | Details | |
| Novartis Investigative Site | Barcelona | 08041 | Spain | Details | ||
| Novartis Investigative Site | Madrid | 28040 | Spain | Details | ||
| Novartis Investigative Site | Zaragoza | 50009 | Spain | Details | ||
| Novartis Investigative Site | Goteborg | 413 45 | Sweden | Details | ||
| Novartis Investigative Site | Lund | SE-221 85 | Sweden | Details | ||
| Novartis Investigative Site | Stockholm | 171 76 | Sweden | Details | ||
| Novartis Investigative Site | Uppsala | SE-751 85 | Sweden | Details | ||
| Novartis Investigative Site | London | W1G 6AD | United Kingdom | Details | ||
| Novartis Investigative Site | Manchester | M20 4BX | United Kingdom | Details |